<DOC>
	<DOC>NCT00604266</DOC>
	<brief_summary>To evaluate the feasibility and performance of coregistered 18F-FDG-PET/MRI in the staging of potentially respectable hilar cholangiocarcinoma.</brief_summary>
	<brief_title>Coregistration of 18F-FDG-PET and MRI in the Staging of Potentially Resectable Hilar Cholangiocarcinoma: a Pilot Study</brief_title>
	<detailed_description />
	<mesh_term>Cholangiocarcinoma</mesh_term>
	<mesh_term>Klatskin Tumor</mesh_term>
	<mesh_term>Fluorodeoxyglucose F18</mesh_term>
	<criteria>Hilar cholangiocarcinoma assessed by conventional imaging modalities (triphasic CT scan of the liver) and thought to be potentially resectable. Biliary drain inserted. Contraindication for MRI. Pregnant or breastfeeding. Uncontrolled diabetes (over 9.7 mmol/L).</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2008</verification_date>
	<keyword>Potentially resectable hilar cholangiocarcinoma as per initial imaging studies.</keyword>
	<keyword>Able to undergo PET/CT and MRI with Gadolinium</keyword>
</DOC>